Company: EverQuote, Inc Symbol: EVER Description: They operate the largest online marketplace for insurance shopping in the United States. Trade Date: 6/28 Shares: 4.7 million Price Range: $15.00-$17.00 Underwriter(s): J.P Morgan, BofA Merrill Lynch Co-Manager(s): Canaccord Genuity, JMP Securities, Needham & Company Oppenheimer & Co., Raymond James, William Blair Terms Added: 6-18-18 Link to Prospectus[…]
Domo Inc #IPO Preview ($DOMO)
Company: Domo, Inc. Symbol: DOMO Description: Domo is an operating system that powers a business, enabling all employees to access real-time data and insights and take action from their smartphone. Trade Date: 6/29 Shares: 9.2 million Price Range: $19.00-$22.00 Underwriter(s): Morgan Stanley, Allen & Company, Credit Suisse, UBS Investment Bank Co-Manager(s): William Blair, JMP Securities,[…]
BrightView Holdings #IPO Preview ($BV)
Company: BrightView Holdings, Inc. Symbol: BV Description: They are the largest provider of commercial landscaping services in the United States, with revenues more than 10 times those of their next largest commercial landscaping competitor. Trade Date: 6/28 Shares: 21.3 million Price Range: $22.00-$25.00 Underwriter(s): Goldman Sachs, J.P. Morgan, KKR, UBS Investment Bank, Baird, Credit Suisse[…]
BJ’s Wholesale Club Holdings, Inc #IPO Preview ($BJ)
Company: BJ’s Wholesale Club Holdings, Inc. Symbol: BJ Description: BJ’s Wholesale Club is a leading warehouse club operator on the East Coast of the United States. Trade Date: 6/28 Shares: 37.5 million Price Range: $15.00-$17.00 Underwriter(s): BofA Merrill Lynch, Deutsche Bank, Goldman Sachs, J.P. Morgan, Morgan Stanley, Citigroup, Jefferies, Wells Fargo Co-Manager(s): Nomura, Baird, Guggenheim,[…]
IPO Pipeline Update (6.15.18)
IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS Company: Navios[…]
Weekly Secondary Performance (6.15.18)
IPO BOUTIQUE is one of the few syndicate services that provides ratings on all secondary offerings (Spots, blocks, marketed). We use our database of historical performances, underwriter trends and more than 40 years of syndicate experience to give our clients a leg up. We meticulously keep records of our ratings. If interested please click below to[…]
IPO Weekly Recap – Software Tech IPOs continue to shine
Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]
Essential Properties Realty Trust, Inc #IPO Preview ($EPRT)
Company: Essential Properties Realty Trust, Inc. Symbol: EPRT Description: They are an internally managed real estate company that acquires, owns and manages primarily single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. Trade Date: 6/21 Shares: 32.5 million Price Range: $14.00-$17.00 Underwriter(s): Goldman Sachs, Citigroup, Barclays,[…]
Eidos Therapeutics, Inc. #IPO Preview ($EIDX)
Company: Eidos Therapeutics, Inc. Symbol: EIDX Description: They are a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. Trade Date: 6/20 Shares: 6.25 million Price Range: $15.00-$17.00 Underwriter(s): J.P. Morgan, BofA Merrill Lynch Co-Manager(s): Barclays Terms Added: 6-8-18 Link to[…]
APTINYX, Inc. #IPO Preview ($APTX)
Company: Aptinyx, Inc. Symbol: APTX Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Trade Date: 6/21 Shares: 5.33 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets Terms Added: 6-11-18[…]
AVROBIO, Inc. #IPO Preview ($AVRO)
Company: AVROBIO, Inc. Symbol: AVRO Description: They are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Trade Date: 6/21 Shares: 4.4 million Price Range: $16.00-$18.00 Underwriter(s): Morgan Stanley, Cowen, Wells Fargo Securities Co-Manager(s): Wedbush Pacgrow Terms Added: 6-11-18 Link[…]
Kezar Life Sciences, Inc. #IPO Preview ($KZR)
Company: Kezar Life Sciences, Inc. Symbol: KZR Description: They are a clinical-stage biotechnology company, discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. Trade Date: 6/21 Shares: 4.67 million Price Range: $14.00-$16.00 Underwriter(s): Jefferies, Cowen, Wells Fargo, William Blair Terms Added: 6-8-18 Link to Prospectus Link to Retail Roadshow[…]
I3 Verticals, Inc. #IPO Preview ($IIIV)
Company: i3 Verticals, Inc. Symbol: IIIV Description: They deliver seamless integrated payment and software solutions to small- and medium-sized businesses and organizations in strategic vertical markets. Trade Date: 6/21 Shares: 6.65 million Price Range: $11.00-$13.00 Underwriter(s): Cowen, Raymond James, KeyBanc Capital Markets Terms Added: 6-11-18 Link to Prospectus Link to Retail Roadshow Business: They have built[…]
Magenta Therapeutics #IPO Preview ($MGTA)
Company: Magenta Therapeutics, Inc. Symbol: MGTA Description: They are a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients. Trade Date: 6/21 Shares: 6.67 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen Co-Manager(s): Wedbush PacGrow Terms Added: 6-8-18 Link to Prospectus Link to Retail[…]
Xeris Pharmaceuticals #IPO Preview ($XERS)
Company: Xeris Pharmaceuticals, Inc. Symbol: XERS Description: They are a specialty pharmaceutical company leveraging our novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations. Trade Date: 6/21 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): Jefferies, Leerink Partners, RBC Capital, Mizuho Securities Terms Added: 6-11-18 Link to[…]
Autolus Therapeutics #IPO Preview ($AUTL)
Company: Autolus Therapeutics Limited Symbol: AUTL Description: They are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. Trade Date: 6/22 Shares: 7.81 million Price Range: $15.00-$17.00 Underwriter(s): Goldman Sachs & Co., Jefferies Co-Manager(s): Wells Fargo Securities, William Blair Terms Added: 6-8-18 Link to Prospectus Link to Retail Roadshow Business: They[…]
Electrocore #IPO Preview ($ECOR)
Company: Electrocore, LLC Symbol: ECOR Description: They are a commercial-stage bioelectronic medicine company with a platform non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology. Trade Date: 6/22 Shares: 4.33 million Price Range: $14.00-$16.00 Underwriter(s): Evercore ISI, JMP Securities, BTIG Terms Added: 6-5-18 Link to Prospectus Link to Retail Roadshow Business: They are a[…]
Secondaries Announced 6.11.18
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPO Pipeline Update – Ending 6.08.18
IPO Boutique keeps apprised of the active pipeline. Currently there are 76 active IPOs in the pipeline as of June 8, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS Company: Forty[…]
IPO Weekly Recap: Opening week of June starts slow
Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish